Clinical Trials

Find trials by condition, location & phase

Drug Monographs

Browse drug monographs and information

Explore organizations and their profiles

Latest updates on trials and healthcare

Approved products by global authorities

AI-Powered Research

Discover powerful insights with advanced AI analysis tools for clinical trials.

Premium Access

Get unlimited access to our comprehensive pharmaceutical database and analytics.

University of Pennsylvania

🇺🇸United States

Country: 🇺🇸United States

Ownership: Private

Established: 1740-11-14

Employees: 5K

Market Cap: -

Website: http://www.upenn.edu

Clinical Trials

Long-term Follow-up of Subjects Exposed to Lentiviral-based CART-EGFRvIII Gene-modified Cellular Therapy Products in Cancer Studies

Completed

Conditions: Subjects Entering Into This Protocol Will be Followed for up to 15 Years After Initial CART-EGFRvIII Infusion

First Posted Date: 2016-01-28

Last Posted Date: 2023-06-22

Lead Sponsor: University of Pennsylvania

Target Recruit Count: 3

Registration Number: NCT02666248

Locations: 🇺🇸
Abramson Cancer Center of the University of Pennsylvania, Philadelphia, Pennsylvania, United States
🇺🇸
University of California, San Francisco, San Francisco, California, United States

Behavioral Economic Approaches to Increase Colorectal Cancer Screening

Not Applicable

Completed

Conditions: Cancer of the Colon

Interventions: Behavioral: Email outreach
Behavioral: Active choice
Behavioral: Financial incentive

First Posted Date: 2016-01-21

Last Posted Date: 2017-05-05

Lead Sponsor: University of Pennsylvania

Target Recruit Count: 2250

Registration Number: NCT02660671

CD22 Redirected Autologous T Cells for ALL

Phase 1

Recruiting

Conditions: B Cell Leukemias
B Cell Lymphomas

Interventions: Biological: Cohort 1
Biological: Cohorts 2
Biological: Cohort 3

First Posted Date: 2016-01-08

Last Posted Date: 2025-03-18

Lead Sponsor: University of Pennsylvania

Target Recruit Count: 41

Registration Number: NCT02650414

Locations: 🇺🇸
Children's Hospital of Philadelphia, Philadelphia, Pennsylvania, United States

Acetaminophen/Codeine vs Acetaminophen/Ibuprofen for Pain Control and Patient Satisfaction After Hand Surgery

Phase 4

Completed

Conditions: Pain, Postoperative

Interventions: Drug: Acetaminophen/Codeine
Drug: Acetaminophen/Ibuprofen

First Posted Date: 2016-01-06

Last Posted Date: 2019-02-18

Lead Sponsor: University of Pennsylvania

Target Recruit Count: 144

Registration Number: NCT02647788

Locations: 🇺🇸
University of Pennsylvania Health System, Philadelphia, Pennsylvania, United States

Improving Coordination and Transitions of Care in Stroke Patients

Not Applicable

Completed

Conditions: Stroke
Transient Ischemic Attack

Interventions: Other: Nursing care model

First Posted Date: 2015-12-30

Last Posted Date: 2024-02-23

Lead Sponsor: University of Pennsylvania

Target Recruit Count: 670

Registration Number: NCT02642744

Locations: 🇺🇸
Hospital of the University of Pennsylvania, Philadelphia, Pennsylvania, United States

Pilot Trial Of Autologous T Cells Engineered To Express Anti-CD19 Chimeric Antigen Receptor (CART19)In Combination With Ibrutinib In Patients With Relapsed Or Refractory CD19+ Chronic Lymphocytic Leukemia (CLL)Or Small Lymphocytic Lymphoma (SLL)

Early Phase 1

Terminated

Conditions: LYMPHOCYTIC LEUKEMIA (CLL) OR SMALL LYMPHOCYTIC LYMPHOMA (SLL)

Interventions: Biological: CART 19

First Posted Date: 2015-12-28

Last Posted Date: 2023-06-22

Lead Sponsor: University of Pennsylvania

Target Recruit Count: 20

Registration Number: NCT02640209

Locations: 🇺🇸
Abramson Cancer Center of the University of Pennsylvania, Philadelphia, Pennsylvania, United States

Behavioral Economics in Provider Incentive Design

Not Applicable

Completed

Conditions: Diabetes

Interventions: Behavioral: Incentive Change

First Posted Date: 2015-12-18

Last Posted Date: 2018-12-12

Lead Sponsor: University of Pennsylvania

Target Recruit Count: 83

Registration Number: NCT02634879

Topical Irrigation Therapy for CRS

Phase 1

Terminated

Conditions: Rhinitis
Sinusitis

Interventions: Drug: Quinine Sulfate
Drug: Placebo

First Posted Date: 2015-12-15

Last Posted Date: 2019-03-13

Lead Sponsor: University of Pennsylvania

Target Recruit Count: 10

Registration Number: NCT02630472

Locations: 🇺🇸
University of Pennsylvania, Philadelphia, Pennsylvania, United States

Intraoperative Imaging of Pituitary Adenomas by OTL

Phase 1

Terminated

Conditions: Neoplasms
Pituitary Neoplasms

Interventions: Drug: OTL38

First Posted Date: 2015-12-14

Last Posted Date: 2019-08-06

Lead Sponsor: University of Pennsylvania

Target Recruit Count: 33

Registration Number: NCT02629549

Locations: 🇺🇸
Hospital of the University of Pennsylvania, Philadelphia, Pennsylvania, United States

Evaluating Incentive Designs to Increase Physical Activity Goal Adherence in a Wellness Program

Phase 3

Withdrawn

Conditions: Physical Activity

Interventions: Behavioral: Active Rewards
Behavioral: Active Rewards Doubled
Behavioral: Lottery 2
Behavioral: Lottery 1
Behavioral: Broadcasting winners

First Posted Date: 2015-12-14

Last Posted Date: 2016-09-29

Lead Sponsor: University of Pennsylvania

Registration Number: NCT02629601

Locations: 🇺🇸
University of Pennsylvania, Philadelphia, Pennsylvania, United States

© Copyright 2025. All Rights Reserved by MedPath

Home Terms & Conditions Privacy Policy